Skip to main content

Jaume Alijotas Reig

Institutions of which they are part

Head of group
Systemic Diseases
Vall Hebron Institut de Recerca

Jaume Alijotas Reig

Institutions of which they are part

Head of group
Systemic Diseases
Vall Hebron Institut de Recerca

Research lines

Immunological alterations as basis of inmunosenescencein pathological aging.

This research line is centered into the study of the role of cross-reactivity among oxidized lipoproteins (oxLDL), antiB2-GP1 and membrane phospholipids, as well as between these complexes and heat shock proteins. We also focus into the role of proinflamatory (IL2 / IL6 / TNFalpha) and anti-inflamatory (IL4 / IL-10) cytokines, as well as with the different activation profiles of TCR and/or CD14 (TLR4) and the role of hormones such as melatonin and the growth hormone.

IP: Jaume Alijotas Reig

Endothelial senescence and their pleiotropic effects onto inflamatory processes, inmunological response and angiogenesis.

Identification at the molecular level of pathways and proteins associated with the senescence of endothelial cells linked to aging and inflamatory responses. New candidate targets for therapeutic intervention at the clinical level and as new molecular moieties for nanomedicine approaches to improve aging related pathologies caused by endothelial inflamatory based senescence.

IP: Jaume Alijotas Reig

Projects

GLOBE: Gestación Ligada a Obesidad y al Entorno. Estudio longitudinal multicéntrico de factores de riesgo asociados a la obesidad en el embarazo

IP: -
Collaborators: Jaume Alijotas Reig, Inés Zulema Calero Fernández, Maite Avilés García
Funding agency: Instituto de Salud Carlos III
Funding: 135883
Reference: PI10/01367
Duration: 01/01/2011 - 31/12/2014

Heparina de Bajo Peso Molecular (HBPM) para la prevención de complicaciones derivadas de la insuficiencia placentaria en las pacientes de riesgo sin trombofilia: estudio multicéntrico randomizado

IP: -
Collaborators: Jaume Alijotas Reig, Inés Zulema Calero Fernández, Elisa Llurba Olivé, Josep Perapoch López
Funding agency: Ministerio Sanidad
Funding: 80000
Reference: EC10-205
Duration: 01/01/2011 - 31/12/2016

Envejecimiento endotelial y sus efectos pleiotrópicos sobre procesos inflamatorios, de la respuesta inmune y angiogénesis

IP: Francesc Miro Mur
Collaborators: Jaume Alijotas Reig, Simon Schwartz Navarro
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 36000
Reference: FMMA/05/2008
Duration: 24/09/2008 - 23/09/2011

CIBER: Bioingenieria, biomateriales y nanomedicina

IP: -
Collaborators: Manuel López Cano, Jaume Alijotas Reig, Francesc Miro Mur, Eloy Espín Basany
Funding agency: CIBER Bioing., Biomateriales y Nanomedicina , BBN
Funding: 480000
Reference: CB06/01/0012
Duration: 01/01/2007 - 31/12/2010

Related news

A Vall d’Hebron team demonstrates, for the first time, the potential of optical genome mapping to detect genetic alterations associated with this rare disease that are not identified using conventional methods.

The study describes the first documented case worldwide of hereditary angioedema transmission through assisted reproduction.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Related professionals

Blanca  Borras  Bermejo

Blanca Borras Bermejo

Predoctoral researcher
Epidemiology and Public Health
Read more
Mauricio Fernando Acuña Vargas

Mauricio Fernando Acuña Vargas

Predoctoral researcher
Neurotraumatology and Neurosurgery Research Unit (UNINN)
Read more
Yolanda Villena Ortiz

Yolanda Villena Ortiz

Predoctoral researcher
Clinical Biochemistry, Drug Delivery & Therapy (CB-DDT)
Read more
Alejandro López Tejedor

Alejandro López Tejedor

Gestió i Administració
Secretariat for Governance and Science Policy
Internal Strategy Directorate
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.